genedrive plc (AIM: GDR)

Market Cap	12.36M
Revenue (ttm)	501.00K
Net Income (ttm)	-7.08M
Shares Out	543.14M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,649,093
Open	2.189
Previous Close	2.100
Day's Range	2.066 - 2.429
52-Week Range	1.208 - 10.000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About genedrive

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides c system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet drug Cl...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 43
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: GDR

Financial Performance

In 2024, genedrive's revenue was 501,000, an increase of 810.91% compared to the previous year's 55,000. Losses were -7.08 million, 37.4% more than in 2023.